Bionomics Limited (NASDAQ:BNOX) Sees Large Growth in Short Interest

Bionomics Limited (NASDAQ:BNOX) saw a significant increase in short interest in the month of June. As of June 15th, there was short interest totalling 388,300 shares, an increase of 410.2% from the May 31st total of 76,100 shares. Based on an average daily trading volume, of 169,300 shares, the days-to-cover ratio is currently 2.3 days.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and issued a $8.00 target price on shares of Bionomics in a report on Wednesday, June 12th.

Bionomics Stock Up 3.5 %

BNOX traded up $0.03 during trading on Friday, reaching $0.77. 58,382 shares of the company’s stock were exchanged, compared to its average volume of 202,793. Bionomics has a fifty-two week low of $0.65 and a fifty-two week high of $6.41. The business has a 50 day moving average price of $0.89 and a 200 day moving average price of $1.04.

Bionomics Company Profile

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder.